Banking of biological fluids for studies of disease-associated protein biomarkers

Molecular and Cellular Proteomics

Volumn 7, Issue 10, 2008, Pages 2061-2066

  Schrohl, Anne Sofie ^a   Würtz, Sidse ^a   Kohn, Elise ^b   Banks, Rosamonde E ^c   Nielsen, Hans Jørgen ^d   Sweep, Fred C G J ^e   Brünner, Nils ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NATIONAL CANCER INSTITUTE   (United States)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^d HVIDOVRE HOSPITAL   (Denmark)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

BODY FLUID; CLINICAL PROTOCOL; DIAGNOSTIC TEST; DISEASE MARKER; HEALTH CARE FACILITY; HUMAN; INFORMATION RETRIEVAL; MEDICAL DECISION MAKING; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DATABASE; PROTEIN EXPRESSION; REVIEW; SAMPLING; SERUM;

BIOLOGICAL MARKERS; BIOLOGICAL SPECIMEN BANKS; BODY FLUIDS; DISEASE; HUMANS; PROTEINS;

EID: 55049130238     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.R800010-MCP200     Document Type: Review

References (26)

1. Bonini, P., Plebani, M., Ceriotti, F., and Rubboli, F. (2002) Errors in laboratory medicine. Clin. Chem. 48, 691-698
2. Lippi, G., Guidi, G. C., Mattiuzzi, C., and Plebani, M. (2006) Preanalytical variability: the dark side of the moon in laboratory testing. Clin. Chem. Lab. Med. 44, 358-365
3. Carraro, P., and Plebani, M. (2007) Errors in a stat laboratory: types and frequencies 10 years later. Clin. Chem. 53, 1338-1342
4. Plebani, M., and Carraro, P. (1997) Mistakes in a stat laboratory: types and frequency. Clin. Chem. 43, 1348-1351
5. Sweep, F. C., Fritsche, H. A., Gion, M., Klee, G. G., and Schmitt, M. (2003) Considerations on development, validation, application, and quality control of immuno(metric) biomarker assays in clinical cancer research: an EORTC-NCI working group report. Int. J. Oncol. 23, 1715-1726
6. Ferguson, R., Hochstrasser, D., and Banks, R. (2007) Impact of pre-analytical variables on the analysis of biological fluids in proteomic studies. Proteomics Clin. Appl. 1, 739-746
7. Claahsen-van der Grinten, H. L., Otten, B. J., Sweep, F. C., Span, P. N., Ross, H. A., Meuleman, E. J., and Hermus, A. R. (2007) Testicular tumors in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency show functional features of adrenocortical tissue. J. Clin. Endocrinol. Metab. 92, 3674-3680
8. Frederiksen, C., Lykke, J., Christensen, I. J., Brunner, N., and Nielsen, H. J. (2007) Tissue inhibitor of metalloproteinase-1 levels in plasma from tumour arteries and veins of patients with rectal cancer. Scand. J. Clin. Lab. Investig. 67, 545-552
9. Wander, K., Brindle, E., and O'Connor, K. A. (2008) C-reactive protein across the menstrual cycle. Am. J. Phys. Anthropol. 136, 138-146
10. Lomholt, A. F., Frederiksen, C. B., Christensen, I. J., Brunner, N., and Nielsen, H. J. (2007) Plasma tissue inhibitor of metalloproteinases-1 as a biological marker? Pre-analytical considerations. Clin. Chim. Acta 380, 128-132
11. Frederiksen, C. B., Lomholt, A. F., Lottenburger, T., Davis, G. J., Dowell, B. L., Blankenstein, M. A., Christensen, I. J., Brunner, N., and Nielsen, H. J. (2008) Assessment of the biological variation of plasma tissue inhibitor of metalloproteinases-1. Int. J. Biol. Markers 23, 42-47
12. Hetland, M. L., Christensen, I. J., Lottenburger, T., Johansen, J. S., Svendsen, M. N., Horslev-Petersen, K., Nielsen, L., and Jorgen, N. H. (2008) Circulating VEGF as a biological marker in patients with rheumatoid arthritis? Preanalytical and biological variability in healthy persons and in patients. Dis. Markers 24, 1-10
13. Sennels, H. P., Jacobsen, S., Jensen, T., Hansen, M. S., Ostergaard, M., Nielsen, H. J., and Sorensen, S. (2007) Biological variation and reference intervals for circulating osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor κB ligand and high-sensitivity C-reactive protein. Scand. J. Clin. Lab. Investig. 67, 821-835
14. Ytting, H., Christensen, I. J., Thiel, S., Jensenius, J. C., Svendsen, M. N., Nielsen, L., Lottenburger, T., and Nielsen, H. J. (2007) Biological variation in circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease-2 and the influence of age, gender and physical exercise. Scand. J. Immunol. 66, 458-464
15. Nielsen, H. J., Brunner, N., Frederiksen, C., Lomholt, A. F., King, D., Jorgensen, L. N., Olsen, J., Rahr, H. B., Thygesen, K., Hoyer, U., Laurberg, S., and Christensen, I. J. (2008) Plasma tissue inhibitor of metalloproteinases-1 (TIMP-1): a novel biological marker in the detection of primary colorectal cancer. Protocol outlines of the Danish-Australian endoscopy study group on colorectal cancer detection. Scand. J. Gastroenterol. 43, 242-248
16. Banks, R. E., Forbes, M. A., Kinsey, S. E., Stanley, A., Ingham, E., Walters, C., and Selby, P. J. (1998) Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br. J. Cancer 77, 956-964
17. Holten-Andersen, M. N., Murphy, G., Nielsen, H. J., Pedersen, A. N., Christensen, I. J., Hoyer-Hansen, G., Brunner, N., and Stephens, R. W. (1999) Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer. Br. J. Cancer 80, 495-503
18. Sorensen, N. M., Schrohl, A. S., Jensen, V., Christensen, I. J., Nielsen, H. J., and Brunner, N. (2008) Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer. Scand. J. Gastroenterol. 43, 186-191
19. Holten-Andersen, M. N., Brunner, N., Christensen, I. J., Jensen, V., and Nielsen, H. J. (2002) Levels of tissue inhibitor of metalloproteinases-1 in blood transfusion components. Scand. J. Clin. Lab. Investig. 62, 223-230
20. Werther, K., Christensen, I. J., and Nielsen, H. J. (2002) Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma. Br. J. Cancer 86, 417-423
21. Riisbro, R., Brunner, N., Christensen, I. J., and Nielsen, H. J. (2004) Soluble urokinase plasminogen activator receptor in blood transfusion components. Transfus. Med. 14, 305-312
22. Edvardsen, L., Taaning, E., Dreier, B., Christensen, L. D., Mynster, T., and Nielsen, H. J. (2001) Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates. Am. J. Hematol. 67, 157-162
23. Nielsen, H. J., Werther, K., Mynster, T., and Brunner, N. (1999) Soluble vascular endothelial growth factor in various blood transfusion components. Transfusion 39, 1078-1083
24. Mynster, T. (2003) Blood transfusion-induced immunomodulation - is storage time important? Dan. Med. Bull. 50, 368-384
25. Holten-Andersen, M. N., Schrohl, A. S., Brunner, N., Nielsen, H. J., Hogdall, C. K., and Hogdall, E. V. (2003) Evaluation of sample handling in relation to levels of tissue inhibitor of metalloproteinases-1 measured in blood by immunoassay. Int. J. Biol. Markers 18, 170-176
26. Rouy, D., Emens, I., Jeanty, C., and Wagner, D. R. (2005) Plasma storage at -80 °C does not protect matrix metalloproteinase-9 from degradation. Anal. Biochem. 338, 294-298